Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection

Graphical abstract

• Publication year

  2020

• Venue

  Virus Research

• Publication date

  2020-09-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.virusres.2020.198169PMID 32979476PMCID 7513916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Coronavirus from Patients with Pneumonia in China, 2019

  2020influential reference
• Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

  2020cited by this paper
• The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

  2020cited by this paper
• Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)

  2020cited by this paper
• Advances in the possible treatment of COVID-19: A review.

  2020cited by this paper
• Vaccination strategies to combat novel corona virus SARS-CoV-2

  2020cited by this paper
• COVID-19: a review.

  2020cited by this paper
• Stilbene-based natural compounds as promising drug candidates against COVID-19

  2020cited by this paper
• The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

  2020cited by this paper
• Antiviral treatment of COVID-19

  2020cited by this paper
• A Review of SARS-CoV-2 and the Ongoing Clinical Trials

  2020influential reference
• Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

  2020cited by this paper
• Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

  2020cited by this paper
• Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient

  2020cited by this paper
• Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites

  2020cited by this paper
• Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil

  2020cited by this paper
• Natural products and their derivatives against coronavirus: A review of the non‐clinical and pre‐clinical data

  2020cited by this paper
• Clinical trials on drug repositioning for COVID-19 treatment

  2020cited by this paper
• The proximal origin of SARS-CoV-2

  2020cited by this paper
• Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

  2020influential reference
• Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses

  2020cited by this paper
• Potential Natural Compounds for Preventing 2019-nCoV Infection

  2020cited by this paper
• A pneumonia outbreak associated with a new coronavirus of probable bat origin

  2020cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Another Decade, Another Coronavirus

  2020cited by this paper
• Membrane binding proteins of coronaviruses

  2019cited by this paper
• Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

  2019cited by this paper
• Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development

  2019influential reference
• Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals

  2019cited by this paper
• Inhibition of SARS-CoV 3CL protease by flavonoids

  2019cited by this paper
• Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses

  2017cited by this paper
• Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors

  2017cited by this paper
• SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION

  2016cited by this paper
• Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor

  2016cited by this paper
• Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV

  2016influential reference
• Herbal plants and plant preparations as remedial approach for viral diseases

  2015cited by this paper
• Potential Antiviral Agents from Marine Fungi: An Overview

  2015cited by this paper
• From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

  2014cited by this paper
• The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family

  2014cited by this paper
• Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia

  2014cited by this paper
• Potential Anti-HPV and Related Cancer Agents from Marine Resources: An Overview

  2014cited by this paper
• The Coronavirus Nucleocapsid Is a Multifunctional Protein

  2014cited by this paper
• Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus.

  2012cited by this paper
• Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13

  2012cited by this paper
• Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein

  2012cited by this paper
• Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase

  2012cited by this paper
• Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication

  2011cited by this paper
• Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study.

  2011cited by this paper
• Synthetic biology approaches in drug discovery and pharmaceutical biotechnology

  2010cited by this paper
• NTPase and 5′ to 3′ RNA Duplex-Unwinding Activities of the Hepatitis E Virus Helicase Domain

  2010cited by this paper
• Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition

  2010cited by this paper
• Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus

  2010cited by this paper
• Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication

  2008cited by this paper
• Immunomodulatory and anti-SARS activities of Houttuynia cordata

  2008cited by this paper
• In vitro susceptibility

  2007cited by this paper
• Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.

  2007influential reference
• Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

  2006cited by this paper
• Understanding helicases as a means of virus control.

  2006cited by this paper
• ANTIVIRAL EFFECTS OF SAIKOSAPONINS ON HUMAN CORONAVIRUS 229E IN VITRO

  2006cited by this paper
• Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3)

  2005cited by this paper
• The Papain-Like Protease from the Severe Acute Respiratory Syndrome Coronavirus Is a Deubiquitinating Enzyme

  2005cited by this paper
• Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

  2005cited by this paper
• The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity

  2005cited by this paper
• Identification of natural compounds with antiviral activities against SARS-associated coronavirus

  2005cited by this paper
• In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds

  2004cited by this paper
• Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells

  2004cited by this paper
• Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

  2003cited by this paper
• Mechanisms and enzymes involved in SARS coronavirus genome expression.

  2003cited by this paper
• Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

  2003cited by this paper
• Induction of inducible nitric oxide synthase expression by 18β‐glycyrrhetinic acid in macrophages

  2002cited by this paper
• Halitunal, an unusual diterpene aldehyde from the marine alga Halimeda tuna

  1991cited by this paper

• Exploration of Baicalin analogues against main Protease involved in Covid-19 as potential inhibitors involving in silico approaches

  2024cites this paper
• High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro

  2024cites this paper
• Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches.

  2024cites this paper
• Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking

  2024cites this paper
• Sites and Zones of Maximum Reactivity of the most Stable Structure of the Receptor-binding Domain of Wild-type SARS-CoV-2 Spike Protein: A Quantum Density Functional Theory Study

  2024cites this paper
• Classification, replication, and transcription of Nidovirales

  2024cites this paper
• Application and mechanism of natural products and nutrient elements in COVID-19

  2024cites this paper
• Evaluating the antiviral efficacy and specificity of chlorogenic acid and related herbal extracts against SARS-CoV-2 variants via spike protein binding intervention

  2024cites this paper
• Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach

  2023cites this paper
• The in-silico potential of Andrographis paniculata phytocompounds as antiviral for the treatment of COVID-19: A systematic review

  2023cites this paper
• The Utilization of Nutraceuticals and Phytochemical Compounds to Inhibit The Interaction of Spike-protein SARS-CoV-2 Virus and ACE-2 Receptor for COVID-19 Therapy (Literature Review)

  2023cites this paper
• Identification of SARS-CoV-2 spike protein inhibitors from Urtica dioica to develop herbal-based therapeutics against COVID-19

  2023cites this paper
• Significant Advancement in Various Synthetic Strategies and Pharmacotherapy of Piperine Derivatives: A Review.

  2023cites this paper
• Multiple Biological Mechanisms for the Potential Influence of Phytochemicals on Physical Activity Performance: A Narrative Review

  2023cites this paper
• Exploring the Impact of Herbal Therapies on COVID-19 and Influenza: Investigating Novel Delivery Mechanisms for Emerging Interventions

  2023cites this paper
• Studi In Silico Senyawa Flavonoid dalam Mengambat RNA-dependent RNA polymerase (RdRp) sebagai Antivirus COVID-19

  2023cites this paper
• Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out

  2023cites this paper
• In Silico Study of Alkaloids: Neferine and Berbamine Potentially Inhibit the SARS-CoV-2 RNA-Dependent RNA Polymerase

  2022cites this paper
• Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection

  2022cites this paper
• Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants

  2022cites this paper
• A global picture: therapeutic perspectives for COVID-19

  2022cites this paper
• Interaction of surface glycoprotein of SARS-CoV-2 variants of concern with potential drug candidates: A molecular docking study

  2022cites this paper
• Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study.

  2022cites this paper
• COVID-19 Crisis, Herbal Medicines, and Natural Products - Concerns and Suggestions

  2022cites this paper
• Inhibitors of SARS-CoV-2 PLpro

  2022cites this paper
• Streptomyces BAC Cloning of a Large-Sized Biosynthetic Gene Cluster of NPP B1, a Potential SARS-CoV-2 RdRp Inhibitor

  2022cites this paper
• Strong anti-SARS-CoV-2 activity of Lucilia cuprina maggots’ excretion/secretion and its effect on viral entry and notch pathway in vitro: First work

  2022cites this paper
• Can plant-derived anti-HIV compounds be used in COVID-19 cases?

  2022cites this paper
• In Silico Approach to Search Various Phytochemicals as Potential Therapeutics Against the Spike Protein from Alpha Variant Strain (B.1.1.7) of SARS-CoV-2

  2022cites this paper
• Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences

  2022cites this paper
• Lead/Drug Discovery from Natural Resources

  2022cites this paper
• In vitro Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2

  2021cites this paper
• Journal of Corona Virus A Brief Review on Covid-19 and Flavonoids Antiviral Effects

  2021influential citation
• Natural and Nature-Derived Products Targeting Human Coronaviruses

  2021cites this paper
• A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19

  2021cites this paper
• Traditional Chinese medicine in COVID-19

  2021cites this paper
• Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses.

  2021cites this paper
• SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

  2021cites this paper
• In Silico Activity Identification of Cyclo Peptide Alkaloids from Zizyphus Spina-Christi Species Against Sars-Cov-2 Main Protease

  2021influential citation
• Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

  2021cites this paper
• Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2

  2021cites this paper
• Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

  2021cites this paper
• Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies

  2021cites this paper
• SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

  2021cites this paper
• The potential of herbal extracts to inhibit SARS-CoV-2: a pilot study

  2021cites this paper
• Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)

  2020cites this paper
• Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives

  2020cites this paper
• A pomegranate peel extract as inhibitor of SARS-CoV-2 Spike binding to human ACE2 (in vitro): a promising source of novel antiviral drugs

  2020cites this paper
• Identi�cation of novel inhibitors of Angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)

  2020cites this paper
• miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19

  2020cites this paper